当前位置: X-MOL 学术Nat. Rev. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP–RTSG 2016 protocol
Nature Reviews Urology ( IF 15.3 ) Pub Date : 2018-02-27 , DOI: 10.1038/nrurol.2018.14
Saskia L. Gooskens , , Norbert Graf , Rhoikos Furtwängler , Filippo Spreafico , Christophe Bergeron , Gema L. Ramírez-Villar , Jan Godzinski , Christian Rübe , Geert O. Janssens , Gordan M. Vujanic , Ivo Leuschner , Aurore Coulomb-L'Hermine , Anne M. Smets , Beatriz de Camargo , Sara Stoneham , Harm van Tinteren , Kathy Pritchard-Jones , Marry M. van den Heuvel-Eibrink

The International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG) has developed a new protocol for the diagnosis, treatment, and follow-up monitoring of childhood renal tumours — the UMBRELLA SIOP–RTSG 2016 protocol (the UMBRELLA protocol). This protocol has been designed to continue international collaboration in the treatment of childhood renal tumours and will be implemented in over 50 different countries. Clear cell sarcoma of the kidney, which is a rare paediatric renal tumour that most commonly occurs in children between 2 and 4 years of age, is specifically addressed in the UMBRELLA protocol.



中文翻译:

立场文件:UMBRELLA SIOP–RTSG 2016协议中治疗CCSK儿童的理由

国际儿科肿瘤学会-肾脏肿瘤研究小组(SIOP-RTSG)已开发出一种用于诊断,治疗和随访监测儿童肾肿瘤的新方案-UMBRELLA SIOP-RTSG 2016方案(UMBRELLA方案)。该协议旨在继续在儿童肾脏肿瘤治疗方面进行国际合作,并将在50多个不同国家/地区实施。肾脏的透明细胞肉瘤是一种罕见的小儿肾脏肿瘤,最常见于2至4岁的儿童,在UMBRELLA协议中有明确规定。

更新日期:2018-02-27
down
wechat
bug